Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (5y) (2014 - 2026)
Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,772.00 |
| Dec 31, 2025 | -47,217.00 |
| Sep 30, 2025 | 3,349.00 |
| Jun 30, 2025 | -24,235.00 |
| Mar 31, 2025 | -15,362.00 |
| Dec 31, 2024 | -31,646.00 |
| Sep 30, 2024 | -1,753.00 |
| Jun 30, 2024 | -27,716.00 |
| Mar 31, 2024 | -42.00 |
| Dec 31, 2023 | -644.00 |
| Sep 30, 2023 | -3,096.00 |
| Jun 30, 2023 | -2,867.00 |
| Mar 31, 2023 | 332.00 |
| Dec 31, 2022 | -2,371.00 |
| Sep 30, 2022 | 47,770.00 |
| Jun 30, 2022 | 7,603.00 |
| Mar 31, 2022 | -805.00 |
| Dec 31, 2021 | 3,939.00 |
| Sep 30, 2021 | -1,376.00 |
| Jun 30, 2021 | 2,049.00 |